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PRACTISE - PhaRmAcist-led CogniTIve Services
in Europe: survey protocol and pilot study
Background and objectives
In 2015, the International Pharmaceutical Federation collected data on
remuneration models for community and hospital pharmacy and identified
large variations highlighting that the focus is largely put on products and
not on cognitive services. 1 Nevertheless the number of pharmacist-led
cognitive services around the world has increased in the last years. 2
Definition of pharmacist-led cognitive service: Service provided or
supervised by the pharmacist, based on a standardized and structured
procedure, for the purpose of promoting optimal health and drug therapy
and that is not necessarily drug or product related. 3 (adapted)
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Clear definitions of terms are pivotal for such an European wide survey
to avoid results based on pseudoconceptions 7 , because the health care
systems across Europe varying a lot and consequently the structure and
content of the provided services in the different countries.
The PRACTISE survey is an ongoing project and the final results shall
be available for the next ESCP in 2017.
DiscussionReferences
Development
- Selection of pharmacist-led cognitive services was based on:
• a previous study by our group 6 / search on official government websites, 
the PCNE wiki and arising links
- Definitions for the selected pharmacist-led cognitive services based on:
• MeSH browser / MEDLINE / Google Scholar / grey literature /internet
Pilot study
The pilot aimed to assess face and content validity main indicators 
(Understanding and extensiveness)  and was undertaken by a steering group 
composed by researchers focusing on pharmaceutical care
Study design main study
• Cross-sectional study design with an online survey
• At least two participants per country/region across Europe, meeting 
specific criteria (research, practice and policy representatives)
Methods
Development
The survey consists of two parts.
• Part A: 21 different pharmacist-led cognitive services (Table 2)
• Part B: focus on medication review services (Table 1)
Pilot study
• Participants:  Slovenia (n=3), Belgium (n=1), Denmark (n=1), Portugal 
(n=2), Finland (n=2), Netherlands (n=1), Switzerland (n=1)
Face and content validity main indicators:
• Understanding: the definition of the service “personalised medicine 
(precision medicine)” was adapted
• Extensiveness: Survey is very/too long service “repeat dispensing” 
was removed in part A,  9 items were removed in part B
• the introductory part was very long /enough space for further   
explanations needed  reduced introductions
Table 2: 21 pharmacist-led cognitive services
Characterisation: Information available:
Type Level Medication 
history
Patient 
interview
Clinical Data
Type 1 Simple +
Type 2a Intermediate + +
Type 2b Intermediate + +
Type 3 Advanced + + +
Table 1: The different types of medication reviews 5
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o Medicines dispensing 
o Adherence support and 
monitoring 
o Administration of injectable 
medicines 
o Assessment of the inhalation 
technique 
o Generic substitution 
o Health screening
o Home delivery of medicines
o Immunisation 
o INR testing and/or 
management
o Opioid substitution treatment
o Needle exchange 
o New medicines service
o Personalised medicine 
(Precision Medicine)
o Pharmaceutical Care 
(Medication Therapy 
Management)
o Point of care testing 
o Prescribing (Under specific 
protocol and/or for specific 
list of medicines) 
o Prescription renewal 
o Provision of emergency oral 
contraception / post-coital 
contraception
o Provision of information on 
medicines 
o Smoking cessation counselling
o Travel medicine
